SYNTHESIS AND EVALUATION OF ANTIMICROBIAL ACTIVITY OF PYRIMIDINE DERIVATIVES by BHAGCHAND JAT et al.
Vol 12, Issue 5, 2019
Online - 2455-3891 
Print - 0974-2441
SYNTHESIS AND EVALUATION OF ANTIMICROBIAL ACTIVITY OF PYRIMIDINE DERIVATIVES
BHAGCHAND JAT1,2, SWAPNA SANTRA1*, PRASANTA KUMAR SANTRA2
1Department of Chemistry, JECRC University, Jaipur, Rajasthan, India. 2Therachem Research Medilab (India) Pvt., Ltd., Sitapura, Jaipur, 
India. Email: swapna.santra@jecrcu.edu.in
Received: 22 November 2018, Revised and Accepted: 30 March 2019
ABSTRACT
Objectives: Synthesis, characterization, and evaluation of antimicrobial activity of novel pyrimidine derivatives containing O, N, and S in the ring.
Methods: Pyrimidine derivatives were prepared in three steps. In the first step, chalcones containing -NO2 functional group were synthesized 
using Claisen-Schmidt condensation of aromatic aldehydes with 2-acetyl pyridine/3-acetylpyridine in methanol in the presence of aqueous NaOH. 
In the second step, -NO2 group was reduced to -NH2 group. Resulting compounds containing NH2 functional group were reacted with different 
dichlorothienopyrimidines and dichlorofuropyrimidines in the presence of N,N-diisopropylethylamine to obtain pyrimidine derivatives.Antibacterial 
and antifungal activity of pyrimidine derivatives were studied in vitro.
Results: Pyrimidine derivatives were synthesized and purified using flash column chromatography. Purity of synthesized pyrimidines was determined 
by high-performance liquid chromatography. Pyrimidines were characterized by elemental analysis, infrared, nuclear magnetic resonance, and mass 
spectral analysis. Analytical data of synthesized pyrimidines supported the proposed structures. Significant antibacterial and antifungal activity were 
observed in the synthesized pyrimidine derivatives.
Conclusion: Antibacterial and antifungal activity of the newly synthesized pyrimidine derivatives will definitely inspire future researchers for the 
preparation of new analogs.
Keywords: 2-Acetylpyridine, 3-Acetylpyridine, Dichlorothienopyrimidines, Dichlorofuropyrimidines, Antibacterial activity and antifungal activity.
INTRODUCTION
Pyrimidine and its derivatives having two nitrogen atoms at 1 
and 3 positions of aromatic ring are found in nature. Pyrimidine 
derivatives synthesized in laboratory are also reported in literature. 
Compounds containing pyrimidine ring already attracted significant 
interest in medicinal chemistry due to their pharmacological and 
biological applications. Antibacterial [1-4], antifungal [5-7], anti-
HIV [8], antitubercular [9], antitumor [10], antineoplastic [11], 
antileishmanial [12], anti-inflammatory [13-15], antidiabetic [16], 
antipyretic [17], antioxidant [18,19], antihistaminic [20], 
anticancer [21,22], and herbicidal [23] properties of pyrimidine 
derivatives are reported in literatures. Pyrimidine derivatives were 
also found to possess potential central nervous system-depressant 
properties [24,25] and to act as blocker of calcium channel [26].
Wide spectrum biological properties of pyrimidine derivatives inspired 
us to synthesize novel pyrimidine derivatives and to study their 
antibacterial and antifungal activities.
METHODS
LR grade chemicals of Sigma-Aldrich, Alfa Aesar, Combi-Blocks, AK 
Scientifics, Avra, and SD-Fine Chem Ltd. were used throughout the 
present investigation. Solvents were dried and distilled before use. 
Progress of reactions was monitored both by thin-layer chromatography 
(TLC) using precoated silica plate (TLC Silica gel 60 F254) and 
high-performance liquid chromatography (HPLC). Flash column 
chromatography technique using silica gel of mesh size 250–450 was 
used to purify crudes. Agilent 1260 series HPLC was used to check the 
purity of pyrimidine derivatives. CHNS analyzer (PerkinElmer 2400) 
was used for elemental analysis. Molecular ions were determined by 
mass spectrometer (Agilent Technologies G1946 D). Infrared (IR) 
spectra were recorded on Agilent Technologies Carry 630. Vibrational 
frequencies are presented in cm−1. 1H nuclear magnetic resonance 
(NMR) spectra were recorded on Bruker Avance, DPX 300 using 
tetramethylsilane as an internal standard and chemical shift values are 
presented in δ ppm.
Scheme 1 was used to synthesis the pyrimidine derivatives.
Step 1A and Step 1B: General method for the synthesis of chalcones
To a stirred solution of 1-(pyridin-3-yl)ethan-1-one/1-(pyridin-
2-yl)ethan-1-one (2.00 g, 16.52 mmol) in 60 mL methanol, 
3-nitrobenzaldehyde (2.49 g, 16.52 mmol) was added at 0°C followed 
by the addition of 3.30 mL of aqueous solution of 1 N NaOH. Resultant 
reaction mixture was stirred first at 0°C for 30 min and then at room 
temperature for 12 h. Progress of the reaction was monitored by TLC 
(mobile phase 80% ethyl acetate [EtOAc] in hexane). The reaction 
mixture was diluted with 80 mL distilled water and was cooled to 0°C. 
10.0 mL 1 N HCl was added to the reaction mixture. Solid was filtered 
to obtain (E)-3-(3-nitrophenyl)-1-(pyridin-3-yl)prop-2-en-1-one 01 
(yield: 3.2 g, 95.23%)/(E)-3-(3-nitrophenyl)-1-(pyridin-2-yl)prop-2-
en-1-one 03 (yield: 3.0 g, 89.28%) as an off white solid.
Step 2A and Step 2B: General method for the reduction of -NO2 
group of chalcones to - NH2 group
Pd/C 5% (0.84 g) was added at room temperature to stirred a 
solution of (E)-3-(3-nitrophenyl)-1-(pyridin-3-yl)prop-2-en-1-
one 01 (1.0 g, 3.94mmol)/(E)-3-(3-nitrophenyl)-1-(pyridin-2-yl)
prop-2-en-1-one 03 (1.0 g, 3.94 mmol) in ethanol (40 mL). Air was 
removed from the reaction flask and hydrogen atmosphere was 
created by hydrogen balloon. Reaction mixture was stirred for 2 h 
at room temperature. Progress of reaction was monitored by TLC 
(mobile phase 5% methanol [MeOH] in dichloromethane [DCM]). 
Reaction mixture was filtered through celite bed and celite bed was 
washed twice with EtOH (2×20.0 mL). Filtrate was concentrated and 
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crude was purified by flash column chromatography using mobile 
phase (0–5% MeOH in DCM). 3-(3-aminophenyl)-1-(pyridin-3-
yl)propan-1-one 2 (yield: 0.5 g, 56.81%) was isolated as a brown 
solid when (E)-3-(3-nitrophenyl)-1-(pyridin-3-yl)prop-2-en-1-one 
1 was used as starting chalcone. Mixture of 3-(3-aminophenyl)-1-
(pyridin-2-yl)propan-1-one 4 and 3-(3-aminophenyl)-1-(pyridin-
2-yl) propan-1-ol 5A were isolated when (E)-3-(3-nitrophenyl)-
1-(pyridin-2-yl)prop-2-en-1-one 3 was used as starting chalcone. 
Crude was purified by flash column chromatography (mobile phase 
0–5% MeOH in DCM) to get title compound 3-(3-aminophenyl)-1-
(pyridin-2-yl)propan-1-one 4 (yield: 0.6 g, 68.18%) as a brown solid 
and 3-(3-aminophenyl)-1-(pyridin-2-yl)propan-1-ol 5A (yield: 0.2 g, 
28.08%) as an oily mass.
Step 3A, 3B.1, and 3B.2: General method for the synthesis of 
pyrimidine derivatives
At room temperature, 2,4-dichlorothieno[2,3-d]pyrimidine/2,4-
dichlorothieno[2 ,3-d]pyrimidine/2,4-dichlorofuro[3 ,2-d]
pyrimidine/2,4-dichloro-5,7-dihydrofuro[3,4-d]pyrimidin(2.65 mmol) 
and N,N-diisopropylethylamine (DIPEA) (0.853 g, 6.6 mmol) were 
added to a stirred a solution of 3-(3-aminophenyl)-1-(pyridin-3-yl)
propan-1-one 2/3-(3-aminophenyl)-1-(pyridin-2-yl)propan-1-one 
4/3-(3-aminophenyl)-1-(pyridin-2-yl)propan-1-ol 5A (2.20 mmol) in 
ethanol (20 mL). Reaction mixture was stirred at room temperature for 
12 h. Progress of reaction was monitored by TLC (mobile phase 0–5% 
MeOH in DCM). Reaction mixture was concentrated and crude was 
purified by flash column chromatography (mobile phase 5% MeOH in 
DCM) to obtain pyrimidine derivatives 5–11 (yield: 20.68, 44.44%) as 
an off white solid to brown solid.
Antibacterial and antifungal activity
Synthesized pyrimidine derivatives were screened for antibacterial 
activity against the bacteria E. coli and Bacillus sphaericus and were 
screened for antifungal activity against the fungus Aspergillus niger and 
Penicillium funiculosum.
Antibacterial assay
In vitro antibacterial activity of synthesized pyrimidine derivatives (in 
DMSO solution at the concentration of 5 mg/mL) was studied as reported 
elsewhere [27] against bacterial strains by the agar well diffusion 
method [28]. Mueller-Hinton agar no. 2 (HiMedia, India) was melted 
and cooled to 48–50°C. Standardized inoculums (1.5×108 CFU/mL, 0.5 
McFarland) were added aseptically to the molten agar and were poured 
into sterile Petri dishes to obtain solid plate. Wells were prepared in 
the seeded agar plates. The test compound (100 μL) was introduced in 
the well (6 mm). Plates were incubated overnight at 37°C. Antibacterial 
spectrum of the test compound was determined for the bacterial species 
in terms of zone sizes around each well. Diameter of inhibition zone 
produced by the test compound was compared with that of standard 
Ciprofloxacin. For each bacterial strain, controls were maintained 
using pure solvent instead of the sample solution. Control zones were 
subtracted from the test zones and the resulting zone diameter was 
measured with antibiotic zone reader to nearest mm. Experiments 
were performed in triplicate.
Scheme 1: Synthesis of pyrimidine derivatives
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Study of antifungal assay
Synthesized pyrimidine derivatives were screened for their antifungal 
activity as reported elsewhere [27] using agar well diffusion method [29]. 
The fungal spore was prepared by sterile PBS. Concentration was 
adjusted to 106 cells/mL by dropping by a sterile swab into the fungal 
suspension and rolled on the surface of the agar medium and plates 
were dried over 20 min at room temperature. Plates were incubated 
at 37°C for 36 h. The diameter of inhibition zone (in mm) produced 
by the subject compound was compared with standard Ketoconazole. 
Experiments were performed in triplicate.
RESULTS AND DISCUSSION
Purity of the synthesized novel pyrimidine derivatives was determined 
by HPLC, characterized by elemental analysis, IR, NMR, and mass 
spectral analysis and was screened for their antibacterial and antifungal 
activity.
Reaction scheme for the synthesis of pyrimidine derivatives is given 
in Scheme 1. Compounds 1, 2, 3, 4, and 5A were prepared as reported 
elsewhere by the authors [25]. In the presence of DIPEA, compounds 3, 





Molecular mass HPLC 
purity (%)




 Off white solid
(M+) 394.9, (M+2) 397.0, 97.88% 60.79 (60.83) 3.84 (3.83) 14.22 (14.19)
2
Brown solid
(M-1) 377.0 98.02% 63.43 (63.41) 4.97 (3.99) 14.81 (14.79)
3
Off white solid
397.1(M+) 398.1(M+2) 99.21% 60.51 (60.53) 4.34 (4.32) 14.11 (14.12)
(Contd...) 
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4
Off white solid
(M+) 397.0, (M+2) 398.7 99.53% 60.55 (60.53) 4.30 (4.32) 14.09 (14.12)
5
Off white solid
(M+) 394.9, (M+2) 397.0 98.09% 60.79 (60.83) 3.82 (3.83) 14.19 (14.19)
6
Brown solid
(M+) 378.8, (M+2) 380.9 96.01% 63.42 (63.41) 4.00 (3.99) 14.80 (14.79)
7
Off white solid
(M-1) 381.1 97.84% 62.72 (62.75) 5.01 (5.00) 14.61 (14.63)
HPLC: High-performance liquid chromatography
Table 1: (Continued)
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4, and 5A containing NH2 functional group were reacted with different 
dichlorothienopyrimidines and dichlorofuropyrimidines at room 
temperature for 12 h to undergo condensation reaction resulting to 
pyrimidine derivatives.
Name, appearance, molecular structure, molecular formula, molecular 
weight, molecular mass ion determined by mass spectrometry, and 
HPLC purity (area %) are presented in Table 1.
Elemental analysis and molecular mass ion determined by mass 
spectrometer supported the molecular formula of the synthesized 
pyrimidine derivatives. The synthesized pyrimidine derivatives exhibited 
characteristic vibration frequency in IR spectra at around 3250–3300 
cm−1 for (OH), at 2920–2978 cm−1 for (C-H, aromatic), at 1620–1699 cm−1 
for (C=O), around 1570–1596 cm−1 for (C=C),at 1525–1575 cm−1 for (C=N, 
aromatic), and at around 700 cm−1 for (C-Cl) supporting the presence 
of functional groups in suggested pyrimidine derivatives. Important 
vibration frequencies in pyrimidine derivatives are reported in Table 2.
1HNMR spectra were recorded in Bruker Avance, DPX 300. Peaks for 
aromatic proton were observed in between 9.16 δ and 6.5 δ. Peaks for 
aliphatic protons are coming in between 1.6 δ and 4.6 δ. Number of 
peaks, relative intensities, and fine structures comply with the proposed 
structures of pyrimidine derivatives. 1HNMR data of pyrimidine 
derivatives are presented in Table 2.
The synthesized pyrimidine derivatives have been screened 
for antibacterial activity against the bacteria Escherichia coli 
and Bacillus sphaericus. Antifungal activity of pyrimidine 
derivative has been screened against fungus Aspergillus niger and 
Penicillium funiculosum. Significant antibacterial activity was 
observed in case of compounds 10 and 11, moderate-to-good 
antibacterial activity was observed in case of compounds 5, 6, and 
8. Compounds 5, 6, and 10 exhibited significant antifungal activity 
against P. funiculosum, whereas moderate antifungal activity was 
observed in case of compounds 7 and 8 against A. niger. Antibacterial 
Table 2: IR, NMR spectral data of pyrimidine derivatives
S. No. Compound IR frequency (in/cm) 1H NMR (in DMSO-d6) chemical shift in ppm
1 1625 cm−1 (C=O), 1571 cm−1 (C=C, 
aromatic), 1526 cm−1 (C=N),  
697 cm−1 (C-Cl)
10.03 (s, 1H), 9.16 (dd, J=2.3, 0.9 Hz, 1H), 8.79 (dd, J=4.8, 
1.7 Hz, 1H), 8.33 (dt, J=8.0, 2.0 Hz, 1H), 7.85 (d, J=6.0 Hz, 
1H), 7.79–7.52 (m, 4H), 7.51–7.25 (m, 1H), 7.12 (d, J=7.6 
Hz, 1H), 3.49 (t, J=7.4 Hz, 2H), 3.00 (t, J=7.4 Hz, 2H)
2 1634 cm−1 (C=O), 1596 cm−1 (C=C, 
aromatic), 1566 cm−1 (C=N),  
698 cm−1 (C-Cl)
δ 10.32 (s, 1H), 9.16 (d, J=2.2 Hz, 1H), 9.01–8.67 (m, 2H), 
8.53–8.26 (m, 2H), 7.66–7.52 (m, 3H), 7.30 (t, J=7.8 Hz, 
1H), 7.13–7.00 (m, 1H), 3.47 (t, J=7.4 Hz, 2H), 2.98  
(t, J=7.3 Hz, 2H)
3 3225 cm−1 (-OH), 1596 cm−1 (C=C, 
aromatic), 1530 cm−1 (C=N),  
697 cm−1 (C-Cl)
δ 10.12 (s, 1H), 8.48 (ddd, J=4.8, 1.8, 1.0 Hz, 1H), 8.26 (d, 
J=5.4 Hz, 1H), 7.79 (td, J=7.7, 1.9 Hz, 1H), 7.62–7.19 (m, 
6H), 7.05 (d, J=7.5 Hz, 1H), 5.50 (d, J=5.1 Hz, 1H), 
4.62 (dt, J=8.9, 4.6 Hz, 1H), 2.70 (t, J=7.9 Hz, 2H), 
2.14–1.77 (m, 2H)
4 3250 cm−1 (-OH), 1572 cm−1 (C=C, 
aromatic), 1530 cm−1 (C=N), 
696 cm−1 (C-Cl)
δ 9.99 (s, 1H), 8.48 (d, J=3.5 Hz, 1H), 7.96–7.62 (m, 3H), 
7.53 (d, J=9.0 Hz, 2H), 7.42–7.20 (m, 3H), 7.02 (d, J=7.6 Hz, 
1H), 5.50 (d, J=5.1 Hz, 1H), 4.61 (s, 1H), 2.70 (t, J=8.1 Hz, 
2H), 1.93 (d, J=7.8 Hz, 2H)
(Contd...) 
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5 1692 cm−1 (C=O), 1573 cm−1 (C=C, 
aromatic), 1526 cm−1 (C=N),  
697 cm−1 (C-Cl)
10.02 (s, 1H), 8.73 (d, J=4.9 Hz, 1H), 8.00 (d, J=7.0 Hz, 
2H), 7.85 (d, J=6.0 Hz, 1H), 7.78–7.62 (m, 3H), 7.58 (s, 
1H), 7.33 (t, J=7.8 Hz, 1H), 7.08 (d, J=7.7 Hz, 1H), 3.57  
(t, J=7.5 Hz, 2H), 3.00 (t, J=7.5 Hz, 2H)
6 1699 (C=O), 1591 cm−1 (C=C, 
aromatic), 1567 cm−1 (C=N),  
697 cm−1 (C-Cl)
10.32 (s, 1H), 8.84–8.56 (m, 1H), 8.40 (d, J=2.2 Hz, 1H), 
8.09–7.91 (m, 2H), 7.77–7.53 (m, 3H), 7.35–7.14  
(m, 1H), 7.14–6.82 (m, 2H), 3.56 (t, J=7.5 Hz, 2H), 2.98  
(t, J=7.5 Hz, 2H)
7 3309 (-OH), 1570 cm−1 (C=C, 
aromatic), 1526 cm−1 (C=N),  
696 cm−1 (C-Cl)
9.54 (s, 1H), 8.49 (dd, J=4.9, 1.8 Hz, 1H), 7.92–7.79 (m, 
1H), 7.54 (dd, J=8.4, 5.1 Hz, 2H), 7.43–7.25 (m, 2H), 
6.98 (d, J=7.8 Hz, 1H), 6.55–6.43 (m, 1H), 5.53 (s, 1H), 
4.92 (s, 2H), 4.83 (t, J=2.7 Hz, 2H), 4.61 (dt, J=8.1, 4.0 Hz, 
1H), 2.68 (t, J=7.8 Hz, 2H), 2.15–1.80 (m, 2H)
activity of pyrimidine derivatives is presented in Table 3 and Fig 1, 
whereas antifungal activity of pyrimidine derivatives is presented in 
Table 4 and Fig 2.
CONCLUSION
Novel pyrimidine derivatives (compounds 5–11) were synthesized and 
screened against E. coli and B. sphaericus with reference to Ciprofloxacin 
and against fungal strains A. niger and P. funiculosum with reference 
to Ketoconazole at the concentration of 1 μg/mL. Good-to-moderate 
Table 2: (Continued)
antibacterial and antifungal activities were observed in some of the 
newly synthesized pyrimidine derivatives.
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5 A 10 0
B 16 8
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B 16 8
7 A 0 16
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8 A 11 6
B 17 10
9 A 6 0
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11 A 11 14
B 20 21
Table 4: Antibacterial activity of pyrimidine derivatives




5 A (40 µl/ml) 0 12
B (80 µl/ml) 0 24
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